Urine survivin, E-cadherin and matrix metalloproteinases as novel biomarkers in children with chronic kidney disease

Biomarkers

Volumn 20, Issue 3, 2015, Pages 177-182

  Musiał, Kinga ^a   Bargenda, Agnieszka ^a   Zwolińska, Danuta ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Apoptosis; epithelial mesenchymal transition; fibrosis; Hsp27; sFas; TGFbeta1

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CREATININE; FAS ANTIGEN; FAS LIGAND; GELATINASE A; GELATINASE B; HEAT SHOCK PROTEIN 27; HEMOGLOBIN; PARATHYROID HORMONE; SURVIVIN; TRANSFORMING GROWTH FACTOR BETA1; UREA; UVOMORULIN; BIOLOGICAL MARKER; BIRC5 PROTEIN, HUMAN; CADHERIN; INHIBITOR OF APOPTOSIS PROTEIN;

ALBUMIN BLOOD LEVEL; APOPTOSIS; ARTICLE; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY FIBROSIS; MALE; PARATHYROID HORMONE BLOOD LEVEL; PROTEINURIA; TISSUE REGENERATION; UREA BLOOD LEVEL; URINALYSIS; ADOLESCENT; BLOOD; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FIBROSIS; INFANT; PATHOLOGY; PRESCHOOL CHILD; RENAL INSUFFICIENCY, CHRONIC; URINE;

ADOLESCENT; APOPTOSIS; BIOMARKERS; CADHERINS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FIBROSIS; GLOMERULAR FILTRATION RATE; HUMANS; INFANT; INHIBITOR OF APOPTOSIS PROTEINS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; RENAL INSUFFICIENCY, CHRONIC; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84940044757     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2015.1061598     Document Type: Article

References (32)

1. Aresu L, Benali S, Garbisa S, et al. (2011). Matrix metalloproteinases and their role in the renal epithelial mesenchymal transition. Histol Histopathol 26: 307-13
2. Chang HR, Yang SF, Li ML, et al. (2006). Relationships between circulating matrix metalloproteinase-2 and-9 and renal function in patients with chronic kidney disease. Clin Chim Acta 366: 243-8
3. Chen J, Chen JK, Conway EM, Harris RC. (2013). Survivin mediates renal proximal tubule recovery from AKI. JASN 24: 2023-33
4. Cheng S, Lovett DH. (2003). Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation. Am J Pathol 162: 1937-49
5. Decleves AE, Sharma K. (2014). Novel targets of antifibrotic and anti-inflammatory treatment in CKD. Nat Rev Nephrol 10: 257-67
6. Eddy AA. (2005). Can renal fibrosis be reversed? Pediatr Nephrol 20: 1369-75
7. Fragiadaki A, Mason RM. (2011). Epithelial-mesenchymal transition in renal fibrosis-evidence for and against. Int J Exp Path 92: 143-50
8. Frisch SM, Schaller M, Cieply B. (2013). Mechanisms that link the oncogenic epithelial-mesenchymal transition to suppression of anoikis. J Cell Sci 126: 21-9
9. Gonzalez-Avila G, Iturria C, Vadillo-Ortega F, et al. (1998). Changes in matrix metalloproteinases during the evolution of interstitial renal fibrosis in a rat experimental model. Pathobiology 66: 196-204
10. Hirt-Minkowski P, Marti HP, Hönger G, et al. (2014). Correlation of serum and urinary matrix metalloproteinases/tissue inhibitors of metalloproteases with subclinical allograft fibrosis in renal transplantation. Transplant Immunol 30: 1-6
11. Iimura O, Takahashi H, Yashiro T, et al. (2004). Effect of ureteral obstruction on matrix metalloproteinase-2 in rat renal cortex. Clin Exp Nephrol 8: 223-9
12. Ku JH, Godoy G, Amiel GE, Lerner SP. (2012). Urine survivin as a diagnostic biomarker for bladder cancer: a systematic review. BJU Int 110: 630-6
13. Liu Y. (2010). New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 21: 212-22
14. Loeffler I, Wolf G. (2014). Transforming growth factor-beta and the progression of renal disease. Nephrol Dial Transplant 29: i37-45
15. Lopez-Hernandez FJ, Lopez-Novoa JM. (2012). Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects. Cell Tissue Res 347: 141-54
16. Lurbe E, Cifkova R, Cruickshank JK, et al. (2009). Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens 27: 1719-42
17. Mandelia A, Bajpai M, Agarwala S, et al. (2013). The role of urinary TGFbeta1, TNFalpha, IL-6 and microalbuminuria for monitoring therapy in posterior urethral valves. Pediatr Nephrol 28: 1991-2001
18. McKittrick IB, Bogaert Y, Nadeau K, et al. (2011). Urinary matrix metalloproteinase activities: biomarkers for plaque angiogenesis and nephropathy in diabetes. Am J Physiol Renal Physiol 301: F1326-33
19. Mehrotra S, Languino LR, Raskett CM, et al. (2010). IAP regulation of metastasis. Cancer Cell 17: 53-64
20. Musiał K, Zwolińska D. (2011). Matrix metalloproteinases (MMP-2,9) and their tissue inhibitors (TIMP-1,2) as novel markers of stress response and atherogenesis in children with chronic kidney disease (CKD) on conservative treatment. Cell Stress Chaperones 16: 97-103
21. Musiał K, Zwolińska D. (2013). New markers of apoptosis in children on chronic dialysis. Apoptosis 18: 77-84
22. Musiał K, Zwolińska D. (2014). Novel indicators of fibrosis-related complications in children with chronic kidney disease. Clin Chim Acta 430: 15-19
23. Onder TT, Gupta PB, Mani SA, et al. (2008). Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 68: 3645-54
24. Pawlak K, Mys̈liwiec M, Pawlak D. (2011). Peripheral blood level alterations of MMP-2 and MMP-9 in patients with chronic kidney disease on conservative treatment and on hemodialysis. Clin Biochem 44: 838-43
25. Prunotto M, Budd DC, Meier M, et al. (2012). From acute injury to chronic disease: pathophysiological hypothesis of an epithelial/mesenchymal crosstalk alteration in CKD. Nephrol Dial Transplant 27: iii43-50
26. Schwartz GJ, Muñoz A, Schneider MF, et al. (2009). New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20: 629-37
27. Taddei ML, Giannoni E, Fiaschi T, Chiarugi P. (2012). Anoikis: an emerging hallmark in health and diseases. J Pathol 226: 380-93
28. Tan TK, Zheng G, Hsu TT, et al. (2010). Macrophage matrix metalloproteinase-9 mediates epithelial-mesenchymal transition in vitro in murine renal tubular cells. Am J Pathol 176: 1256-70
29. Tang Y, Kesavan P, Nakada MT, Yan L. (2004). Tumor-stroma interaction: positive feedback regulation of extracellular matrix inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. Mol Cancer Res 2: 73-80
30. Vianna HR, Soares CM, Silveira KD, et al. (2013). Cytokines in CKD: potential link of MCP-1 and dyslipidemia in glomerular diseases. Pediatr Nephrol 28: 463-9
31. Visse R, Nagase H. (2003). Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function and biochemistry. Circ Res 92: 827-39
32. Yoo ChB, Yun SM, Jo Ch, Koh YH. (2012). γ-Secretase-dependent cleavage of E-cadherin by staurosporine in breast cancer cells. Cell Commun Adhesion 19: 11-16